DETAILED NOTES ON DATOPOTAMAB DERUXTECAN

mitotane will decrease the extent or effect of abemaciclib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Coadministration of abemaciclib with strong CYP3A4 inducers reduces plasma focus of abemaciclib and its metabolites.dabrafenib will lessen the level or impact of abemaciclib by impacting hepatic/intestina